Johnson & Johnson Reports Tremfya Sales Growth of 68.2% in 3Q
Tremfya worldwide operational sales reached $2.4 billion, up 68.2% in the third quarter, helping cushion Stelara sales erosion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.